Advertorial

GEA and Perceptive Engineering – a partnership for the global pharmaceutical industry

2
SHARES

Posted: 25 May 2018 | | No comments yet

GEA and Perceptive Engineering have announced a collaboration to promote and deploy cutting-edge multivariate monitoring and Advanced Process Control (APC) solutions for batch and continuous pharmaceutical process units…

VanguardHouse

The partnership will further enhance GEA’s ConsiGma® platform for oral solid dose (OSD) pharmaceutical development and manufacturing by offering Perceptive’s “out of the box” APC and monitoring capabilities. The continuous monitoring of product quality can prevent out-of-specification deviations and decrease production costs, as well as reducing final quality inspections by facilitating real-time release testing.

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

The partnership builds on the successful implementation of Perceptive’s APC platform into the first-generation PCMM (portable, continuous, miniature and modular) platform for the development and production of pharmaceutical OSDs. Originally conceived in conjunction with Pfizer and G-CON, the three companies formed a consortium to design and build a portable, autonomous manufacturing environment for continuous OSD production using GEA’s ConsiGma® 25 equipment and G-CON’s modular POD system. A prototype unit is currently being implemented at Pfizer’s labs in Groton (Connecticut, USA).

This collaboration also builds on the previously announced relationship between GEA and Siemens, as well as the existing association between Siemens and Perceptive. Together, this provides a leading-edge, industrially proven solution for pharmaceutical manufacturers, comprising both hardware and software platforms, as well as PAT integration, process monitoring, process analytics, control and optimisation. This complete, seamless suite is designed to help pharma companies exploit the opportunities presented by moving to continuous manufacturing.

To find out more, and learn about ACHEMA, please visit the GEA website: 

https://www.gea.com/en/news/trade-press/2018/perceptive-engineering-monitoring-control-system.jsp

To learn more about Perceptive Engineering’s solutions for pharmaceutical manufacturing, please visit: 

http://www.perceptiveapc.com/industries/pharmaceuticals/

Share via
Share via